Product Information
OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by BluePoint Laboratories, priced at $2.9636 per ML under NDC 68001067492. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Feb 28, 2025.
Strength
2 mg/mL
Manufacturer
BluePoint LaboratoriesNDC
68001067492
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA219557FDA Approved
2/28/2025
On Market Since
9/15/2025
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9636 per ML |
|---|---|
| All-time high | $3.3966 (Jan 14, 2026) |
| All-time low | $2.9636 (Sep 23, 2026) |
| 52-week high | $3.3966 |
| 52-week low | $2.9636 |
| Median price | $3.1742 |
| Average price | $3.1555 |
| Largest weekly change | -3.3% (Jun 17, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OLOPATADINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by BluePoint Laboratories, is $2.9636 per ML (NDC 68001067492), effective Sep 30, 2026.
How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 12.7%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?
Since Dec 17, 2025, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.9636 (Sep 23, 2026) to a high of $3.3966 (Jan 14, 2026), with a median of $3.1742 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLOPATADINE HCL 0.2% EYE DROP, is $1.9835 per ML — about 33% below OLOPATADINE HCL 0.2% EYE DROP.
Who manufactures OLOPATADINE HCL 0.2% EYE DROP?
OLOPATADINE HCL 0.2% EYE DROP (NDC 68001067492) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.